PVLA
Palvella Therapeutics
$147.47
+$14.55 (+10.95%)Oct 28, 2026
Key metrics
The numbers that frame PVLA today
- Market cap
- $2.12B
- ROIC
- -242%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $68.96
- 52wk High
- $161.38
Growth
Revenue and earnings trend for PVLA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PVLA
Is Palvella Therapeutics a good buy?
Hold. Palvella Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Palvella Therapeutics is selling at a high price.
What is the market capitalization of PVLA?
Palvella Therapeutics's market capitalization is $2.12B.
What is the 52-week high for PVLA stock?
The 52-week high for Palvella Therapeutics is $161.38. The current close of $147.47 is 8.6% below that high.
What is the 52-week low for PVLA stock?
The 52-week low for Palvella Therapeutics is $68.96. The current close of $147.47 is 113.8% above that low.
Does PVLA stock pay dividends?
Palvella Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PVLA?
Palvella Therapeutics's Debt / Equity ratio is 0.